Search for: "State v. Janssen"
Results 221 - 239
of 239
Sort by Relevance
|
Sort by Date
13 Aug 2008, 5:00 am
Janssen Pharmaceutica, Inc., No. 07-12259, slip op. (11th Cir. [read post]
11 Jul 2008, 4:30 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: ACTA continues to be discussed and debated: (Michael Geist), (Intellectual Property Watch), (Public Knowledge), (Techdirt), (Managing Intellectual Property), (Public Knowledge), (Public Knowledge), (Public Knowledge), Apotex challenge to Acular LS patent barred by res judicata: Roche Palo Alto & Allergan v Apotex:… [read post]
5 Jul 2008, 11:05 am
interview: (IP tango) Events 7 July: PLI briefing webcast ‘Life after Quanta v LGE: What every patent lawyer needs to know’: (PLI), 7-15 July/16-18 July: 2nd Transatlantic IP summer academy, modules one and two – Alicante/Milan: (IPKat), 9 July 2008: ALI & ABA webcast ‘Quanta v LG: What you should know’: (Patent Docs), 11 July: CIPA moot to improve participants’ understanding of procedures of EPO Technical… [read post]
28 Jun 2008, 11:06 pm
V. [read post]
20 Jun 2008, 8:07 am
: (Spicy IP), Latin America: Merck Serono signs distribution agreement with Bristol-Myers Squibb for portfolio of established pharmaceutical brands in Latin America: (IP tango), US: Biotech industry growth to slow due to funding pressures and competition from biosimilars: (Managing Intellectual Property), US: House Commerce Committee posts responses to its questions on biogenerics; not surprisingly, the views run the gamut: (FDA Law Blog), US: Biosimilar debate heats up at BIO: (Managing… [read post]
7 Mar 2008, 5:47 am
Ranbaxy Laboratories Ltd. v. [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
4 Mar 2008, 1:49 am
Janssen, discussing the new Federal Rules of Civil Procedure and their impact on litigators can be downloaded at [feeds.feedburner]. com/Westcast. [read post]
29 Feb 2008, 8:00 am
– Teva’s opposition proceedings regarding IL 130424 to Pfizer: (IP Factor), Thailand: Thai chief drug price negotiator removed from post: (GenericsWeb), Thailand: Compulsory licences cannot be revoked: (Generic Pharmaceuticals & IP), (more from Generic Pharmaceuticals & IP), UK: Court of Appeal for England and Wales hands down decision in Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited relating to repackaging and… [read post]
15 Aug 2007, 7:49 am
Hendleson v. [read post]
6 Jul 2007, 4:29 am
We've already deplored the recent decision of the West Virginia Supreme Court rejecting the learned intermediary rule outright, State ex rel. [read post]
5 Jul 2007, 10:37 am
Code §11-1-63(c)(ii); Janssen Pharmaceutica, Inc. v. [read post]
18 Jun 2007, 4:26 pm
The case is Lee Hendelson v. [read post]
31 May 2007, 4:31 am
Janssen Pharmaceutica, Inc., 2006 WL 3665417, at *2 (S.D. [read post]
7 May 2007, 4:14 am
**UPDATEThe orangebook blog noted on May 13, 2007, concerning Janssen Pharmaceutica et al. v. [read post]
12 Apr 2007, 1:33 am
See State v. [read post]
16 Mar 2007, 5:59 am
State and Janssen v. [read post]
29 Dec 2006, 3:26 pm
State of Indiana (NFP) Janssen Hamlett v. [read post]
19 Dec 2006, 6:22 am
State; Kolb v. [read post]
